1Laing NG,Davis MR,Bayley K,et al.Molecular diagnosis of duchenne muscular dystrophy:past,present and future in relation to implementing therapies[J].Clin Biochem Rev,2011,32(3):129-134.
2Beck AJ,Vitale JM,Zhao Q,et al.Differential requirement for utrophin in the induced pluripotent stem cell correction of muscle versus fat in muscular dystrophy mice[J].PLoS One,2011,6(5):20065.
3Baltgalvis KA,Call JA,Nikas JB,et al.The effects of prednisolone on skeletal muscle contractility in mdx mice[J].Muscle Nerve,2009,40(3):443-454.
4Alexander MS,Casar JC,Motohashi N,et al.Regulation of DMD pathology by an ankyrin-encoded miRNA[J].Skelet Muscle,2011,1:27.
5Pikó H,Nagy B,Balog J,et al.Carrier detection in families affected by Duchenne/Becker muscular dystrophy[J].Orv Hetil,2007,148(51):2403-2409.
6Desguerre I,Christov C,Mayer M,et al.Clinical heterogeneity of duchenne muscular dystrophy(DMD):definition of sub-phenotypes and predictive criteria by long-term follow-up[J].PloS One,2009,4(2):4347.
7Zhou L,Rafael-Fortney JA,Huang P,et al.Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice[J].J Neurol Sci,2008,264(1/2):106-111.
8Payam SMD,Michael J,Friez PD,et al.Clinical and genetic characterization of manifesting carriers of dMD mutations[J].Neuromuscul Disord,2010,20(8):499-504.
9Zhang YZ,Xiong H.Phenotype analysis and follow-up study on patients with Duchenne/Becker muscular dystrophy[J].Beijing Da Xue Xue Bao,2010,42(6):661-666.
3Mendell JR, Shilling C, Leslie ND, et al. Evidence-based path to newborn screening for duchenne muscular dystrophy [ J ]. Ann Neurol, 2012, 71(3):304-313.
4Manzur AY, Kuntzer T, Pike M, et al. Glucocorticoid corticosteroids for Duchenne muscular dystrophy [ J ] . Cochrane Database Syst Rev,2008( 1 ) :D3725.
5Theadom A, Rodrigues M, Roxburgh R, et al. Prevalence of Muscular Dystrophies: A Systematic Literature Review [ J ] Neuroepidemiology, 2014, 43 (3-4):259-268.
6Balaban B, Matthews DJ, Clayton GH, et al. Corticosteroid treatment and functional improvement in Duehenne muscular dystrophy: long-term effect[ J]. Am J Phys Med Rehabil,2005,84 ( 11 ) :843-850.
7King WM, Ruttencutter R, Nagaraja HN, et al. Orthopedic outcomes of long-term daily cortieosteroid treatment in Duehenne muscular dystrophy[ J]. Neurology ,2007,68 (19) : 1607-1613.
8Hussein G, Mansour L, Ghafar HA, et al. Short-term effects of corticosteroid therapy on cardiac and skeletal muscles in muscular dystrophies[J]. J Investig Med,2014,62(6) :875-879.
9Hussein MRA, Abu-Dief EE, Kamel NF, et al. Steroid therapy is associated with decreased numbers of dendritic ceils and fibroblasts, and increased numbers of satellite ceils, in the dystrophic skeletal muscle [ J ]. J Clin Pathol, 2010,63 ( 9 ) : 805- 813.
10Rifai Z, Welle S, Moxley RR, et al. Effect of prednisone on protein metabolism in Duchenne dystrophy [ J ]. Am J Physiol, 1995,268( 1 Pt 1 ) :E67-E74.
